Juste Catherine
UEPSD (Unité d'écologie et de physiologie du système digestif), INRA, Domaine de Vilvert, 78352 Jouy-en-Josas Cedex.
Bull Cancer. 2005 Jul;92(7):708-21.
The interactions between dietary fatty acids (FA) and the intestinal microbiota were reviewed, with their possible relationships to colon and breast cancers. Free and esterified FA in the colon are from dietary, endogenous and microbial origin. Their quantity and quality vary according to dietary FA. Some FA but not all are powerful antimicrobial agents, and different bacteria exhibit distinct sensitivity to FA. These data converge to suggest that dietary FA could influence the biodiversity of the intestinal microbiota and its functions. Conversely, bacteria can modify lipid substrates due to their enormous metabolic potential, and several studies demonstrated that dietary FA did influence the nature of the metabolites produced. Some of these, like hydroxylated FA or sn-1,2-diglycerides, have recognized biological activities on the intestinal mucosa, either as surfactants or intracellular messengers. The intestinal microbiota also represents a substantial source of usual and unusual FA whose biological activities remain to be explored. Dietary FA can influence the secretion of bile and bile acids into the duodenum, the bile acid flux and/or concentration into the feces and that of cholesterol and its bacterial products. This is expected to modify the cytotoxicity of the colonic contents which remains to be evaluated under different lipid diets. Lastly, the intestinal microbiota is very efficient in hydrolyzing conjugated endobiotics and xenobiotics, and this favours the reactivation and the enterohepatic circulation of compounds which have been eliminated through the bile. Hormones are especially concerned, and the intestinal microbiota could thus be implicated in breast cancer. Some dietary FA are known to increase bacterial beta-glucuronidases whereas their effect on other bacterial hydrolases or other enzymes capable of modifying the steroid nucleus remains unknown. In conclusion, numerous data suggest that a strong relationship could exist between dietary FA, the intestinal microbiota and the risk of colon and breast cancer. In the same time, data are still fragmentary so that the effects of dietary FA on the overall biodiversity and numerous functions of the intestinal microbiota cannot be hitherto predicted. Future investigations in this field are discussed.
本文综述了膳食脂肪酸(FA)与肠道微生物群之间的相互作用,以及它们与结肠癌和乳腺癌可能存在的关系。结肠中的游离脂肪酸和酯化脂肪酸来自饮食、内源性和微生物来源。它们的数量和质量因膳食脂肪酸而异。一些脂肪酸(但并非全部)是强大的抗菌剂,不同细菌对脂肪酸表现出不同的敏感性。这些数据表明膳食脂肪酸可能会影响肠道微生物群的生物多样性及其功能。相反,由于细菌具有巨大的代谢潜力,它们可以改变脂质底物,多项研究表明膳食脂肪酸确实会影响所产生代谢物的性质。其中一些代谢物,如羟基化脂肪酸或sn-1,2-甘油二酯,作为表面活性剂或细胞内信使,对肠黏膜具有公认的生物活性。肠道微生物群也是常见和不常见脂肪酸的重要来源,其生物活性仍有待探索。膳食脂肪酸可影响胆汁和胆汁酸向十二指肠的分泌、胆汁酸进入粪便的通量和/或浓度,以及胆固醇及其细菌产物的分泌。这有望改变结肠内容物的细胞毒性,而这仍有待在不同脂质饮食条件下进行评估。最后,肠道微生物群在水解结合型内源性和外源性物质方面非常有效,这有利于已通过胆汁消除的化合物的再激活和肠肝循环。激素尤其受到影响,因此肠道微生物群可能与乳腺癌有关。已知一些膳食脂肪酸会增加细菌β-葡萄糖醛酸酶,而它们对其他细菌水解酶或其他能够修饰甾体核的酶的影响尚不清楚。总之,大量数据表明膳食脂肪酸、肠道微生物群与结肠癌和乳腺癌风险之间可能存在密切关系。同时,数据仍然零散,因此膳食脂肪酸对肠道微生物群整体生物多样性和多种功能的影响目前尚无法预测。本文讨论了该领域未来的研究方向。